![Philippe Weigerstorfer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Weigerstorfer
Direktor/Vorstandsmitglied bei
SONOMA PHARMACEUTICALS, INC.
Vermögen: - $ am 31.05.2026
Profil
Philippe Weigerstorfer is Chairman at Onycho Pharma Pte Ltd. since 2020 and Independent Director at Sonoma Pharmaceuticals, Inc. since 2018.
Former roles include Executive Chairman at Galencia AB from 2000 to 2016, Managing Director at Vifor Pharma Asia Pacific Pte Ltd. from 2011 to 2017, Head-Corporate Development Division at Corden Pharma Fribourg SA from 1999 to 2011, Head-Corporate Marketing & Dermatology at Novartis AG from 1996 to 1999, Director at Aspreva Pharmaceuticals Corp., Head-Dermatology & Cardiovascular at Sandoz Pharmaceuticals AG.
Education includes undergraduate studies at the University of Basel.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Philippe Weigerstorfer
| Unternehmen | Position | Beginn |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 19.09.2018 |
Onycho Pharma Pte Ltd. | Vorsitzender | 01.01.2020 |
Ehemalige bekannte Positionen von Philippe Weigerstorfer
| Unternehmen | Position | Ende |
|---|---|---|
Vifor Pharma Asia Pacific Pte Ltd.
 Vifor Pharma Asia Pacific Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures iron, kidney and cardio renal medicines | Vorstandsvorsitzender | 01.01.2017 |
Galencia AB | Vorsitzender | 01.01.2016 |
| VIFOR PHARMA | Corporate Officer/Principal | 01.07.2011 |
| NOVARTIS AG | Corporate Officer/Principal | 01.01.1999 |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Develops and produces biopharmaceuticals | Corporate Officer/Principal | - |
Ausbildung von Philippe Weigerstorfer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Sonoma Pharmaceuticals, Inc.
 Sonoma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells stabilized hypochlorous acid | Health Technology |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Develops and produces biopharmaceuticals | Health Technology |
Onycho Pharma Pte Ltd. | |
Vifor Pharma Asia Pacific Pte Ltd.
Vifor Pharma Asia Pacific Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures iron, kidney and cardio renal medicines | Health Technology |
Galencia AB |
